摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-chloro-6-(2-fluorophenyl)-3a,4-dihydro-1H-imidazo<1,5-a><1,4>benzodiazepine 2-oxide | 76489-15-1

中文名称
——
中文别名
——
英文名称
8-chloro-6-(2-fluorophenyl)-3a,4-dihydro-1H-imidazo<1,5-a><1,4>benzodiazepine 2-oxide
英文别名
8-chloro-6-(2-fluorophenyl)-3a,4-dihydro-1H-imidazo[1,5-a][1,4]benzodiazepine 2-oxide;8-chloro-6-(2-fluorophenyl)-2-oxido-3a,4-dihydro-1H-imidazo[1,5-a][1,4]benzodiazepin-2-ium
8-chloro-6-(2-fluorophenyl)-3a,4-dihydro-1H-imidazo<1,5-a><1,4>benzodiazepine 2-oxide化学式
CAS
76489-15-1
化学式
C17H13ClFN3O
mdl
——
分子量
329.761
InChiKey
JAJRGLDLDPTJMW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    23
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    44.4
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 1,2,5-Oxadiazino[5,4-a][1,4]benzodiazepine derivatives
    申请人:Hoffmann-La Roche Inc.
    公开号:US04226771A1
    公开(公告)日:1980-10-07
    A multistep process is presented for the preparation of imidazobenzodiazepines of the formula ##STR1## wherein X is selected from the group consisting of hydrogen, halogen, nitro and trifluoromethyl, Y is selected from the group consisting of hydrogen, halogen and trifluoromethyl and R.sub.1 is selected from the group consisting of hydrogen, lower alkyl and aryl Also presented are novel intermediates utilized in the process. The end products are useful as sedatives, anxiolytics, muscle relaxants and anticonvulsants. The end products are especially useful in intravenous compositions for use in preoperative anesthesia.
    提供了一种多步骤过程,用于制备公式##STR1##的咪唑苯二氮䓬。其中X从氢、卤素、硝基和三氟甲基组成的组中选择,Y从氢、卤素和三氟甲基组成的组中选择,R.sub.1从氢、较低烷基和芳基组成的组中选择。该过程中使用的新型中间体也被提出。最终产品可用作镇静剂、抗焦虑药、肌肉松弛剂和抗惊厥药。最终产品在静脉注射组合物中特别适用于术前麻醉使用。
  • Process for the preparation of imidazobenzodiazepines
    申请人:Hoffmann-La Roche Inc.
    公开号:US04240962A1
    公开(公告)日:1980-12-23
    A multistep process is presented for the preparation of imidazobenzodiazepines of the formula ##STR1## wherein X is selected from the group consisting of hydrogen, halogen, nitro and trifluoromethyl, Y is selected from the group consisting of hydrogen, halogen and trifluoromethyl and R.sub.1 is selected from the group consisting of hydrogen, lower alkyl and aryl Also presented are novel intermediates utilized in the process. The end products are useful as sedatives, anxiolytics, muscle relaxants and anticonvulsants. The end products are especially useful in intravenous compositions for use in preoperative anesthesia.
    提出了一种多步骤的过程,用于制备式为##STR1##的咪唑苯二氮平,其中X选自氢、卤素、硝基和三氟甲基的群体,Y选自氢、卤素和三氟甲基的群体,R.sub.1选自氢、低碳基和芳基的群体。还提出了在过程中使用的新型中间体。最终产品可用作镇静剂、抗焦虑药、肌肉松弛剂和抗惊厥药。最终产品在术前麻醉的静脉注射组合物中特别有用。
  • Imidazobenzodiazepines
    申请人:Hoffmann-La Roche Inc.
    公开号:US04250095A1
    公开(公告)日:1981-02-10
    A multistep process is presented for the preparation of imidazobenzodiazepines of the formula ##STR1## wherein X is selected from the group consisting of hydrogen, halogen, nitro and trifluoromethyl, Y is selected from the group consisting of hydrogen, halogen and trifluoromethyl and R.sub.1 is selected from the group consisting of hydrogen, lower alkyl and aryl. Also presented are novel intermediates utilized in the process. The end products are useful as sedatives, anxiolytics, muscle relaxants and anticonvulsants. The end products are especially useful in intravenous compositions for use in preoperative anesthesia.
    提供了一种制备式为##STR1##的咪唑苯并二氮平的多步骤过程,其中X选自氢、卤素、硝基和三氟甲基的群组,Y选自氢、卤素和三氟甲基的群组,R.sub.1选自氢、低烷基和芳基的群组。还提供了在该过程中使用的新型中间体。最终产品可用作镇静剂、抗焦虑剂、肌肉松弛剂和抗癫痫药物。最终产品在术前麻醉的静脉注射组合物中特别有用。
  • WALSER, A.;FRYER, R. I., J. HETEROCYCL. CHEM., 1983, 20, N 3, 551-558
    作者:WALSER, A.、FRYER, R. I.
    DOI:——
    日期:——
  • US4226771A
    申请人:——
    公开号:US4226771A
    公开(公告)日:1980-10-07
查看更多